Trials / Completed
CompletedNCT00941239
Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)
Gastric Tolerability and Pharmacokinetics of an Extended Release Metformin and an Immediate Release Metformin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Laboratorios Silanes S.A. de C.V. · Industry
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the gastric tolerability and the pharmacokinetics of an extended release metformin compared with an immediate release metformin in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | metformin ER | 850mg daily for 30 days |
| DRUG | metformin | 850 mg daily for 30 days |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2009-07-17
- Last updated
- 2018-01-30
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00941239. Inclusion in this directory is not an endorsement.